Advancements in nanotechnology: mRNA vaccines for infectious diseases and cancer immunotherapy driving the future of global health

Advancements in nanotechnology: mRNA vaccines for infectious diseases and cancer immunotherapy driving the future of global health

Saved in:

Bibliographic Details
Main Author:	Jeeva Jothi Kumaravel
Format:	Article
Language:	English
Published:	Elsevier 2024-06-01
Series:	Oral Oncology Reports
Online Access:	http://www.sciencedirect.com/science/article/pii/S2772906024003005
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Comment on “Advancements in nanotechnology: mRNA vaccines for infectious diseases and cancer immunotherapy driving the future of global health”
by: Surya Parthasarathy, et al.
Published: (2024-09-01)

mRNA vaccine platforms: linking infectious disease prevention and cancer immunotherapy
by: Dariush Haghmorad, et al.
Published: (2025-03-01)

Emerging Immunotherapies in Lung Cancer: The Latest Advances and the Future of mRNA Vaccines
by: Raquel Ramos, et al.
Published: (2025-04-01)

Research progress of mRNA vaccines for infectious diseases
by: Zhen Zhang, et al.
Published: (2025-08-01)

mRNA Vaccines Against Infectious Diseases and Cancer
by: Alexander Meisel, et al.
Published: (2021-10-01)

mRNA mediates passive vaccination against infectious agents, toxins, and tumors
by: Moritz Thran, et al.
Published: (2017-08-01)

The role of mRNA vaccines in infectious diseases: a new era of immunization
by: Kesaobaka Batisani
Published: (2025-05-01)

mRNA vaccines and SiRNAs targeting cancer immunotherapy: challenges and opportunities
by: Zhen Lv, et al.
Published: (2025-07-01)

Computational biology and artificial intelligence in mRNA vaccine design for cancer immunotherapy
by: Saber Imani, et al.
Published: (2025-01-01)

Emerging prospects of mRNA cancer vaccines: mechanisms, formulations, and challenges in cancer immunotherapy
by: Umm E. Laila, et al.
Published: (2024-11-01)

Development of mRNA rabies vaccines
by: Zixin Fang, et al.
Published: (2024-12-01)

mRNA cancer vaccines from bench to bedside: a new era in cancer immunotherapy
by: Alireza Shariati, et al.
Published: (2024-12-01)

Advances in mRNA vaccine therapy for breast cancer research
by: Jia-ying Li, et al.
Published: (2025-05-01)

Recent progress in mRNA cancer vaccines
by: Ruhui Yao, et al.
Published: (2024-12-01)

Antitumor mRNA vaccines based on neoantigens
by: E. V. Starostina, et al.
Published: (2025-01-01)

Targeting tumor-associated macrophages for anti-cancer activity and its pathway
by: Jeeva Jothi Kumaravel, et al.
Published: (2024-06-01)

mRNA vaccine quality analysis using RNA sequencing
by: Helen M. Gunter, et al.
Published: (2023-09-01)

Comparing Moderna’s mRNA-1083 and Pfizer’s dual-target mRNA vaccines for influenza and COVID-19
by: Adewunmi Akingbola, et al.
Published: (2025-05-01)

Deep Learning-based Predictive Model of mRNA Vaccine Deterioration: An Analysis of the Stanford COVID-19 mRNA Vaccine Dataset
by: Nisreen Sulayman
Published: (2023-08-01)

mRNA-based vaccines for the prevention of coronavirus infection
by: S. M. Kharit, et al.
Published: (2022-04-01)

Thyroiditis after mRNA Vaccination for COVID-19
by: Arunava Saha, et al.
Published: (2022-01-01)

Tailoring mRNA lipid nanoparticles for antifungal vaccines.
by: Yeqi Li, et al.
Published: (2025-04-01)

mRNA Vaccine Technology Beyond COVID-19
by: Sola Oloruntimehin, et al.
Published: (2025-05-01)

mRNA vaccine designs for optimal adjuvanticity and delivery
by: Yuki Mochida, et al.
Published: (2024-12-01)

Cancer Vaccines and Beyond: The Transformative Role of Nanotechnology in Immunotherapy
by: Violeta Delgado-Almenta, et al.
Published: (2025-02-01)

Future Impact of mRNA Therapy on Cardiovascular Diseases
by: John P. Cooke, et al.
Published: (2022-12-01)

Nanoparticle-Based mRNA Vaccine Induces Protective Neutralizing Antibodies Against Infectious Bronchitis Virus in In-Vivo Infection
by: Aseno Sakhrie, et al.
Published: (2025-05-01)

A Systematic Review of Clinical Trials Using mRNA Vaccines for Infectious Diseases other than COVID-19
by: Athina Sofroniou, et al.
Published: (2025-07-01)

Nanotechnology-driven advances in intranasal vaccine delivery systems against infectious diseases
by: Zhihan Zhang, et al.
Published: (2025-05-01)

Integrating IL-12 mRNA nanotechnology with SBRT eliminates T cell exhaustion in preclinical models of pancreatic cancer
by: Angela L. Hughson, et al.
Published: (2024-12-01)

Seasonal influenza vaccine performance and the potential benefits of mRNA vaccines
by: Colin A. Russell, et al.
Published: (2024-12-01)

Recent Advances in mRNA-Based Vaccines Against Several Hepatitis Viruses
by: Rafid Jihad Albadr, et al.
Published: (2025-06-01)

A Luciferase-Based Approach for Functional Screening of 5′ and 3′ Untranslated Regions of the mRNA Component for mRNA Vaccines
by: Maria Rubtsova, et al.
Published: (2025-05-01)

An mRNA lipid nanoparticle-incorporated nanofiber-hydrogel composite for cancer immunotherapy
by: Yining Zhu, et al.
Published: (2025-07-01)

Revolutionizing Dentistry: Preclinical Insights and Future Applications of mRNA Vaccines in Dentistry—A Narrative Review
by: Luciana Koren, et al.
Published: (2025-02-01)

Innovation in mRNA Vaccines and RNAi via Protein Nanocages
by: Sohrab Ahmadivand
Published: (2025-06-01)

Safety and immunogenicity of an mRNA-1273 vaccine booster in adolescents
by: Amparo L. Figueroa, et al.
Published: (2025-12-01)

Harnessing mRNA vaccines for viral diseases: bottleneck and breakthrough
by: Vijay Mishra, et al.
Published: (2025-08-01)

iDC-targeting PfCSP mRNA vaccine confers superior protection against Plasmodium compared to conventional mRNA
by: Sean Yanik, et al.
Published: (2025-02-01)

Rational optimization of glycoprotein E (gE)-encoding mRNA for improved Varicella-zoster virus mRNA vaccine development
by: Lulu Huang, et al.
Published: (2024-12-01)